ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
asx11
|
2.2K |
765K |
17 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
2.2K
|
765K
|
17
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
asx11
|
11K |
3.9M |
3 |
27/05/24 |
27/05/24 |
General
|
11K
|
3.9M
|
3
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm Successfully Completes A$20.0 Million Placement
|
|
asx11
|
16 |
4.7K |
1 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
16
|
4.7K
|
1
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm Successfully Completes A$20.0 Million Placement
|
|
asx11
|
16 |
4.7K |
1 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
16
|
4.7K
|
1
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm Successfully Completes A$20.0 Million Placement
|
|
asx11
|
16 |
4.7K |
0 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
16
|
4.7K
|
0
|
|
ASX - By Stock
|
CYC |
Re:
Ann: Cyclopharm Successfully Completes A$20.0 Million Placement
|
|
asx11
|
16 |
4.7K |
1 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
16
|
4.7K
|
1
|
|
ASX - By Stock
|
BOT |
Re:
Sp trajectory post approval
|
|
asx11
|
22 |
13K |
17 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
22
|
13K
|
17
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
asx11
|
9.6K |
3.6M |
4 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
9.6K
|
3.6M
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
asx11
|
126 |
31K |
1 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
126
|
31K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
asx11
|
126 |
31K |
2 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
126
|
31K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
asx11
|
126 |
31K |
6 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
126
|
31K
|
6
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
asx11
|
390 |
165K |
0 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
390
|
165K
|
0
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
asx11
|
14K |
5.0M |
12 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
14K
|
5.0M
|
12
|
|
ASX - By Stock
|
BOT |
Re:
Bot Chart
|
|
asx11
|
14K |
5.0M |
9 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
14K
|
5.0M
|
9
|
|
ASX - By Stock
|
PAR |
Re:
FDA approval timeline and follow up timeline
|
|
asx11
|
6 |
2.1K |
1 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
6
|
2.1K
|
1
|
|
ASX - By Stock
|
4DX |
Re:
Ann: 4DMedical gains US CMS reimbursement for CT LVAS
|
|
asx11
|
27 |
10K |
4 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
27
|
10K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Michael Kelso etc
|
|
asx11
|
12 |
3.8K |
1 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
12
|
3.8K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
asx11
|
234 |
64K |
9 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
234
|
64K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
asx11
|
234 |
64K |
19 |
19/05/24 |
19/05/24 |
ASX - By Stock
|
234
|
64K
|
19
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Licenses Allogeneic CD19 CAR T Cell Therapy
|
|
asx11
|
506 |
231K |
0 |
18/05/24 |
18/05/24 |
ASX - By Stock
|
506
|
231K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
asx11
|
4.4K |
2.0M |
4 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Where will we be in 12 months time?
|
|
asx11
|
255 |
102K |
17 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
255
|
102K
|
17
|
|
ASX - By Stock
|
BOT |
Re:
Where will we be in 12 months time?
|
|
asx11
|
255 |
102K |
12 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
255
|
102K
|
12
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
asx11
|
9.6K |
3.6M |
11 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
9.6K
|
3.6M
|
11
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
|
|
asx11
|
104 |
32K |
6 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
104
|
32K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
I made it back into Green today! (A Cathartic Experiment)
|
|
asx11
|
1 |
787 |
3 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
1
|
787
|
3
|
|
ASX - By Stock
|
BOT |
Re:
Where will we be in 12 months time?
|
|
asx11
|
255 |
102K |
5 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
255
|
102K
|
5
|
|
ASX - By Stock
|
SHG |
Re:
Ann: Significant Follow On Investment from Marin & Sons
|
|
asx11
|
29 |
7.7K |
3 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
29
|
7.7K
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
asx11
|
11K |
3.9M |
2 |
15/05/24 |
15/05/24 |
General
|
11K
|
3.9M
|
2
|
|
ASX - By Stock
|
BOT |
Re:
Where will we be in 12 months time?
|
|
asx11
|
255 |
102K |
4 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
255
|
102K
|
4
|
|
ASX - By Stock
|
BOT |
Re:
Where will we be in 12 months time?
|
|
asx11
|
255 |
102K |
8 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
255
|
102K
|
8
|
|
ASX - By Stock
|
SHG |
Re:
Ann: Significant Follow On Investment from Marin & Sons
|
|
asx11
|
29 |
7.7K |
5 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
29
|
7.7K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RAC Investor Presentation May 2024
|
|
asx11
|
55 |
16K |
6 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
55
|
16K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
|
|
asx11
|
104 |
32K |
0 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
104
|
32K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
|
|
asx11
|
104 |
32K |
17 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
104
|
32K
|
17
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RAC Investor Presentation May 2024
|
|
asx11
|
55 |
16K |
6 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
55
|
16K
|
6
|
|
ASX - By Stock
|
TBN |
Re:
Let's guess the US offering price.
|
|
asx11
|
119 |
32K |
1 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
119
|
32K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
asx11
|
4.4K |
2.0M |
1 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
4.4K
|
2.0M
|
1
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
asx11
|
234 |
64K |
3 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
234
|
64K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
asx11
|
234 |
64K |
25 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
234
|
64K
|
25
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
asx11
|
234 |
64K |
11 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
234
|
64K
|
11
|
|
ASX - By Stock
|
BOT |
Re:
Where will we be in 12 months time?
|
|
asx11
|
255 |
102K |
6 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
255
|
102K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
Where will we be in 12 months time?
|
|
asx11
|
255 |
102K |
6 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
255
|
102K
|
6
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
asx11
|
9.6K |
3.6M |
6 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
9.6K
|
3.6M
|
6
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
asx11
|
9.6K |
3.6M |
7 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
9.6K
|
3.6M
|
7
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
asx11
|
9.6K |
3.6M |
10 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
9.6K
|
3.6M
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Speculative M&A Transaction Analysis
|
|
asx11
|
740 |
279K |
6 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
740
|
279K
|
6
|
|